Are We Ready for Fragile X Newborn Screening Testing?—Lessons Learnt from a Feasibility Study
AbstractFragile X syndrome (FXS) is the most prevalent heritable cause of cognitive impairment but is not yet included in a newborn screening (NBS) program within Australia. This paper aims to assess the feasibility and reliability of population screening for FXS using a pilot study in one hospital. A total of 1971 mothers consented for 2000 newborns to be tested using routine NBS dried blood spot samples. DNA was extracted and a modified PCR assay with a chimeric CGG primer was used to detect fragile X alleles in both males and females in the normal, premutation, and full mutation ranges. A routine PCR-based fragile X assay was run in parallel to validate the chimeric primer assay. Babies with CGG repeat number ≥59 were referred for family studies. One thousand nine hundred and ninety NBS samples had a CGG repeat number less than 55 (1986 < 50); 10 had premutation alleles >54 CGG repeats (1/123 females and 1/507 males). There was complete concordance between the two PCR-based assays. A recent review revealed no clinically identified cases in the cohort up to 5 years later. The cost per test was $AUD19. Fragile X status can be determined on routine NBS samples using the chimeric primer assay. However, whilst this assay may not be considered cost-effective for population screening, it could be considered as a second-tier assay to a developed immunoassay for fragile X mental retardation protein (FMRP). View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Wotton, T.; Wiley, V.; Bennetts, B.; Christie, L.; Wilcken, B.; Jenkins, G.; Rogers, C.; Boyle, J.; Field, M. Are We Ready for Fragile X Newborn Screening Testing?—Lessons Learnt from a Feasibility Study. Int. J. Neonatal Screen. 2018, 4, 9.
Wotton T, Wiley V, Bennetts B, Christie L, Wilcken B, Jenkins G, Rogers C, Boyle J, Field M. Are We Ready for Fragile X Newborn Screening Testing?—Lessons Learnt from a Feasibility Study. International Journal of Neonatal Screening. 2018; 4(1):9.Chicago/Turabian Style
Wotton, Tiffany; Wiley, Veronica; Bennetts, Bruce; Christie, Louise; Wilcken, Bridget; Jenkins, Gemma; Rogers, Carolyn; Boyle, Jackie; Field, Michael. 2018. "Are We Ready for Fragile X Newborn Screening Testing?—Lessons Learnt from a Feasibility Study." Int. J. Neonatal Screen. 4, no. 1: 9.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.